{"errors":{},"id":3747579,"source_code":"DMDRN","source_name":"Damodaran Financial Data","code":"BTHE_ALLFINANCIALRATIOS","name":"Boston Therapeutics Inc ( BTHE ) - All Financial Ratios","urlize_name":"Boston-Therapeutics-Inc-BTHE-All-Financial-Ratios","description":"Corporate Finance data is collected and calculated by Prof. Aswath\nDamodaran, Professor of Finance at the Stern School of Business, New\nYork University.  The raw data is available here:\nhttp://pages.stern.nyu.edu/~adamodar/New_Home_Page/data.html","updated_at":"2014-03-14T00:35:35Z","frequency":"annual","from_date":"2012-12-31","to_date":"2012-12-31","column_names":["Date","Number of Shares Outstanding","Book Debt to Capital Ratio","Book Value of Equity","Book Value of Assets","Capital Expenditures","Cash","Cash as Percentage of Firm Value","Cash as Percentage of Total Assets","Depreciation","Dividend Yield","Dividends","Effective Tax Rate","Enterprise Value","EV to Invested Capital Ratio","Firm Value","Ratio of Fixed Assets to Total Assets","Hi-Lo Risk","Ratio of Intangible Assets to Total Assets","Invested Capital","Market Capitalization","Market Debt to Equity Ratio","Market Debt to Capital Ratio","Net Income","Non-Cash Working Capital","Price to Book Value Ratio","Reinvestment Amount","Return on Equity","Sales General and Administration Expenses","Stock Price","Total Debt","Trading Volume","EV to Book Value Ratio"],"private":false,"type":null,"display_url":"http://pages.stern.nyu.edu/~adamodar/New_Home_Page/data.html","data":[["2012-12-31",16.2,0.4286,0.4,1.1,0.0,0.2,0.0247,0.1818,0.1,0.0,0.0,0.0,7.9,15.8,8.1,0.0,0.6154,0.8182,0.5,7.8,0.0385,0.037,-0.8,-0.4,19.5,-0.1,-2.0,0.6,0.42,0.3,0.0,11.57]]}